133 related articles for article (PubMed ID: 34152076)
1. Application of the ACMG/NSGC genetic referral guidelines for hereditary renal cell carcinoma at the University of Miami, from 2014 to 2017.
Leuchter JD; Patel PM; Fourzali KM; Donenberg TR; Silva-Smith R; Vassallo NC; Blanton SH; Parekh DJ; Forghani I
Am J Med Genet A; 2021 Oct; 185(10):3012-3018. PubMed ID: 34152076
[TBL] [Abstract][Full Text] [Related]
2. Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.
Truong H; Hegarty SE; Gomella LG; Kelly WK; Trabulsi EJ; Lallas CD; Giri VN
J Genet Couns; 2017 Jun; 26(3):548-555. PubMed ID: 28101821
[TBL] [Abstract][Full Text] [Related]
3. A practice guideline from the American College of Medical Genetics and Genomics and the National Society of Genetic Counselors: referral indications for cancer predisposition assessment.
Hampel H; Bennett RL; Buchanan A; Pearlman R; Wiesner GL;
Genet Med; 2015 Jan; 17(1):70-87. PubMed ID: 25394175
[TBL] [Abstract][Full Text] [Related]
4. Outcome of genetic evaluation of patients with kidney cancer referred for suspected hereditary cancer syndromes.
Stratton KL; Alanee S; Glogowski EA; Schrader KA; Rau-Murthy R; Klein R; Russo P; Coleman J; Offit K
Urol Oncol; 2016 May; 34(5):238.e1-7. PubMed ID: 26723226
[TBL] [Abstract][Full Text] [Related]
5. Identification of women at risk for hereditary breast and ovarian cancer in a sample of 1000 Slovenian women: a comparison of guidelines.
Kotnik U; Peterlin B; Lovrecic L
BMC Cancer; 2021 Jun; 21(1):665. PubMed ID: 34082720
[TBL] [Abstract][Full Text] [Related]
6. Genetic risk assessment for hereditary renal cell carcinoma: Clinical consensus statement.
Bratslavsky G; Mendhiratta N; Daneshvar M; Brugarolas J; Ball MW; Metwalli A; Nathanson KL; Pierorazio PM; Boris RS; Singer EA; Carlo MI; Daly MB; Henske EP; Hyatt C; Middleton L; Morris G; Jeong A; Narayan V; Rathmell WK; Vaishampayan U; Lee BH; Battle D; Hall MJ; Hafez K; Jewett MAS; Karamboulas C; Pal SK; Hakimi AA; Kutikov A; Iliopoulos O; Linehan WM; Jonasch E; Srinivasan R; Shuch B
Cancer; 2021 Nov; 127(21):3957-3966. PubMed ID: 34343338
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Germline Mutations in Cancer Susceptibility Genes in Patients With Advanced Renal Cell Carcinoma.
Carlo MI; Mukherjee S; Mandelker D; Vijai J; Kemel Y; Zhang L; Knezevic A; Patil S; Ceyhan-Birsoy O; Huang KC; Redzematovic A; Coskey DT; Stewart C; Pradhan N; Arnold AG; Hakimi AA; Chen YB; Coleman JA; Hyman DM; Ladanyi M; Cadoo KA; Walsh MF; Stadler ZK; Lee CH; Feldman DR; Voss MH; Robson M; Motzer RJ; Offit K
JAMA Oncol; 2018 Sep; 4(9):1228-1235. PubMed ID: 29978187
[TBL] [Abstract][Full Text] [Related]
8. Defining early-onset kidney cancer: implications for germline and somatic mutation testing and clinical management.
Shuch B; Vourganti S; Ricketts CJ; Middleton L; Peterson J; Merino MJ; Metwalli AR; Srinivasan R; Linehan WM
J Clin Oncol; 2014 Feb; 32(5):431-7. PubMed ID: 24378414
[TBL] [Abstract][Full Text] [Related]
9. Diagnosis and Management of Hereditary Renal Cell Cancer.
Menko FH; Maher ER
Recent Results Cancer Res; 2016; 205():85-104. PubMed ID: 27075350
[TBL] [Abstract][Full Text] [Related]
10. 40 years and beyond for the National Society of Genetic Counselors: Reflections on genetic counseling practice.
Uhlmann WR; Hoskovec J; Freivogel M
J Genet Couns; 2020 Dec; 29(6):888-893. PubMed ID: 32643233
[TBL] [Abstract][Full Text] [Related]
11. Implications of ACMG guidelines to identify high-risk acute lymphoblastic leukemia patients with hereditary cancer susceptibility syndromes (HCSS) in a highly consanguineous population.
Aslam S; Shabana ; Ahmed M
BMC Pediatr; 2021 Jun; 21(1):282. PubMed ID: 34134655
[TBL] [Abstract][Full Text] [Related]
12. Hereditary Leiomyomatosis and Renal Cell Cancer: Clinical, Molecular, and Screening Features in a Cohort of 185 Affected Individuals.
Forde C; Lim DHK; Alwan Y; Burghel G; Butland L; Cleaver R; Dixit A; Evans DG; Hanson H; Lalloo F; Oliveira P; Vialard L; Wallis Y; Maher ER; Woodward ER
Eur Urol Oncol; 2020 Dec; 3(6):764-772. PubMed ID: 31831373
[TBL] [Abstract][Full Text] [Related]
13. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
14. Quality of cancer family history and referral for genetic counseling and testing among oncology practices: a pilot test of quality measures as part of the American Society of Clinical Oncology Quality Oncology Practice Initiative.
Wood ME; Kadlubek P; Pham TH; Wollins DS; Lu KH; Weitzel JN; Neuss MN; Hughes KS
J Clin Oncol; 2014 Mar; 32(8):824-9. PubMed ID: 24493722
[TBL] [Abstract][Full Text] [Related]
15. Application of Hereditary Renal Cell Carcinoma Risk Criteria to a Large Prospective Database.
Kushnir I; Kirk L; Mallick R; Kim RH; Graham GE; Breau RH; Lattouf JB; Violette PD; Pautler SE; Care M; Kapoor A; Jewett MAS; Wood L; Tanguay S; Heng DYC; Basappa NS; So A; Pouliot F; Reaume NM
Clin Oncol (R Coll Radiol); 2020 Jan; 32(1):e10-e15. PubMed ID: 31378448
[TBL] [Abstract][Full Text] [Related]
16. Renal cell cancers: unveiling the hereditary ones and saving lives-a tailored diagnostic approach.
Kallinikas G; Habib H; Tsimiliotis D; Koutsokostas E; Bokor B
Int Urol Nephrol; 2017 Sep; 49(9):1507-1512. PubMed ID: 28567709
[TBL] [Abstract][Full Text] [Related]
17. Hereditary renal cell carcinoma syndromes: diagnosis, surveillance and management.
Maher ER
World J Urol; 2018 Dec; 36(12):1891-1898. PubMed ID: 29680948
[TBL] [Abstract][Full Text] [Related]
18. Exploring the hereditary background of renal cancer in Denmark.
Christensen MB; Wadt K; Jensen UB; Lautrup CK; Bojesen A; Krogh LN; Overeem Hansen TV; Gerdes AM
PLoS One; 2019; 14(4):e0215725. PubMed ID: 31034483
[TBL] [Abstract][Full Text] [Related]
19. Genetic kidney cancer syndromes.
Ho TH; Jonasch E
J Natl Compr Canc Netw; 2014 Sep; 12(9):1347-55. PubMed ID: 25190700
[TBL] [Abstract][Full Text] [Related]
20. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]